Helen Ha

1.2k total citations · 1 hit paper
12 papers, 810 citations indexed

About

Helen Ha is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Helen Ha has authored 12 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Helen Ha's work include Chemokine receptors and signaling (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and CAR-T cell therapy research (2 papers). Helen Ha is often cited by papers focused on Chemokine receptors and signaling (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and CAR-T cell therapy research (2 papers). Helen Ha collaborates with scholars based in United States, Germany and Belgium. Helen Ha's co-authors include Nouri Neamati, Bikash Debnath, Frauke Christ, Alexander Shekhtman, Subhabrata Majumder, Teshome Leta Aboye, Julio A. Camarero, Zeger Debyser, Henry C. Ho and Paul M. Beringer and has published in prestigious journals such as Nature Communications, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Helen Ha

11 papers receiving 800 citations

Hit Papers

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Ha United States 9 336 328 310 87 75 12 810
Devin B. Lowe United States 16 248 0.7× 412 1.3× 445 1.4× 75 0.9× 113 1.5× 38 841
A. Nazmul H. Khan United States 14 406 1.2× 451 1.4× 251 0.8× 52 0.6× 43 0.6× 19 844
Ramireddy Bommireddy United States 14 225 0.7× 278 0.8× 152 0.5× 63 0.7× 38 0.5× 34 615
Nahum Puebla‐Osorio United States 19 469 1.4× 366 1.1× 314 1.0× 180 2.1× 96 1.3× 43 1.0k
Kathryn Smart United Kingdom 15 259 0.8× 552 1.7× 480 1.5× 67 0.8× 56 0.7× 23 1.1k
Krishna Mohan Sepuru United States 16 271 0.8× 314 1.0× 193 0.6× 41 0.5× 49 0.7× 31 814
Xiuyan Yu China 16 412 1.2× 264 0.8× 277 0.9× 208 2.4× 107 1.4× 35 916
Zhan Wang China 15 245 0.7× 307 0.9× 272 0.9× 128 1.5× 130 1.7× 39 764
F. Jon Geske United States 9 282 0.8× 224 0.7× 158 0.5× 72 0.8× 48 0.6× 12 671

Countries citing papers authored by Helen Ha

Since Specialization
Citations

This map shows the geographic impact of Helen Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Ha more than expected).

Fields of papers citing papers by Helen Ha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Ha. The network helps show where Helen Ha may publish in the future.

Co-authorship network of co-authors of Helen Ha

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Ha. A scholar is included among the top collaborators of Helen Ha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Ha. Helen Ha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Heard, Amanda, John M. Warrington, John Lattin, et al.. (2022). Antigen glycosylation regulates efficacy of CAR T cells targeting CD19. Nature Communications. 13(1). 3367–3367. 40 indexed citations
2.
Heard, Amanda, John Lattin, Jufang Chang, et al.. (2021). Antigen Glycosylation Is a Central Regulator of CAR T Cell Efficacy. Blood. 138(Supplement 1). 1721–1721. 1 indexed citations
3.
Li, Hao, et al.. (2017). DMH4, a VEGFR2 inhibitor, effectively suppresses growth and invasion of lung cancer cells. Journal of Applied Biomedicine. 16(1). 46–50. 3 indexed citations
4.
Ha, Helen, Bikash Debnath, & Nouri Neamati. (2017). Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases. Theranostics. 7(6). 1543–1588. 562 indexed citations breakdown →
5.
Ghedan, Shawket, et al.. (2016). Full Field Chemical EOR in a Mature Southern Alberta Water Flooded Reservoir - The Little Bow Case Study. SPE EOR Conference at Oil and Gas West Asia. 2 indexed citations
6.
Ha, Helen, Bikash Debnath, Srinivas Odde, et al.. (2015). Discovery of Novel CXCR2 Inhibitors Using Ligand-Based Pharmacophore Models. Journal of Chemical Information and Modeling. 55(8). 1720–1738. 21 indexed citations
7.
Ha, Helen & Nouri Neamati. (2014). Pyrimidine-Based Compounds Modulate CXCR2-Mediated Signaling and Receptor Turnover. Molecular Pharmaceutics. 11(7). 2431–2441. 15 indexed citations
8.
Ha, Helen, et al.. (2013). Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives. Bioorganic & Medicinal Chemistry Letters. 23(22). 6156–6160. 12 indexed citations
9.
Ha, Helen, et al.. (2013). A novel phenylcyclohex‐1‐enecarbothioamide derivative inhibits CXCL8‐mediated chemotaxis through selective regulation of CXCR2‐mediated signalling. British Journal of Pharmacology. 171(6). 1551–1565. 12 indexed citations
10.
Card, Colin, et al.. (2013). Incorporating 4D Seismic Steam Chamber Location Information into Assisted History Matching for A SAGD Simulation. SPE Heavy Oil Conference-Canada. 11 indexed citations
11.
Aboye, Teshome Leta, Helen Ha, Subhabrata Majumder, et al.. (2012). Design of a Novel Cyclotide-Based CXCR4 Antagonist with Anti-Human Immunodeficiency Virus (HIV)-1 Activity. Journal of Medicinal Chemistry. 55(23). 10729–10734. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026